Patent landscape analysis of mRNA Covid-19 vaccine technology: examining the role of biotech companies, public research and universities

Fabio Montobbio, Gabriele Pellegrino and Valerio Sterzi

Chapter 24 in Handbook of Innovation and Intellectual Property Rights, 2024, pp 417-439 from Edward Elgar Publishing

Abstract: This chapter analyzes the patent landscape of the mRNA Covid-19 vaccine technology. It shows the growth of patents in this field, the share of patents held by various biotechnological companies and the important role of universities and research centers. This chapter also provides initial evidence regarding the growth of patent litigation cases and infringement actions caused by the start of large-scale production. The chapter discusses two critical issues. (1) The role of university patents and the link between scientific research in universities and public research centers and the commercialization and development of the final products. (2) The fragmentation of intellectual property and how, in these circumstances, it could increase transaction costs and barriers to entry.

Keywords: Business and Management; Economics and Finance; Innovations and Technology; Law - Academic (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.elgaronline.com/doi/10.4337/9781800880627.00034 (application/pdf)
Our link check indicates that this URL is bad, the error code is: 503 Service Temporarily Unavailable

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:elg:eechap:20438_24

Ordering information: This item can be ordered from
http://www.e-elgar.com

Access Statistics for this chapter

More chapters in Chapters from Edward Elgar Publishing
Bibliographic data for series maintained by Darrel McCalla ().